Allergy/Immunology
- Clinical trials: More to learn than the results
The details of the GIACTA trial challenge and reaffirm some of our clinical impressions about giant cell arteritis.
- Giant cell arteritis: An updated review of an old disease
Glucocorticoids, the mainstay of treatment, should be started as soon as the disease is suspected.
- Subclinical hypothyroidism February 2019
The article: Azim S, Nasr C. Subclinical hypothyroidism: When to treat. Cleve Clin J Med 2019; 86(2):101–110. doi:10.3949/ccjm.86a.17053 contained an error.
- Pyoderma gangrenosum mistaken for diabetic ulcer
A man with type 2 diabetes, hypertension, anemia, and ulcerative colitis presented with an ulcer on his leg.
- Laboratory tests in rheumatology: A rational approach
Negative results are not always reassuring, and false-positive results pose risks.
- Subclinical hypothyroidism: When to treat
The decision remains controversial and depends on the degree of TSH elevation, thyroid antibodies, and comorbidities.
- There is more to the TSH than a number
Management of subclinical hypothyroidism should be nuanced and based on clinical and laboratory parameters.
- MGUS: It’s about the protein, not just the marrow
What is a cause of a high erythrocyte sedimentation rate with a normal C-reactive protein and a low anion gap?
- Who needs to carry an epinephrine autoinjector?
Patients who have had anaphylaxis or who are at risk of it should carry an epinephrine autoinjector with them at all times.
- Small fibers, large impact
The wide interest in small fi ber neuropathy may reflect our current apparent epidemic of chronic pain.